Clinical Trial Update: GLP1R in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on GLP1R targeting therapy for Parkinson's disease is reported, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Oslo University Hospital | Conditions: Parkinson Disease | Phase 2 | Status: UNKNOWN